GoLiver Therapeutics is the winner of the French Government‘s «Recovery plan for industry – strategic sectors» call for the implementation of its industrial manufacturing platform project aimed at developing a biomedicine from pluripotent stem cells The aim of this project is to manufacture, in France, a cell therapy product from pluripotent stem cells for the […]
03/2021: GOLIVER THERAPEUTICS IS THE WINNER OF THE FRENCH GOVERNMENT’S « RECOVERY PLAN FOR INDUSTRY – STRATEGIC SECTORS » CALL FOR THE IMPLEMENTATION OF ITS INDUSTRIAL MANUFACTURING PLATFORM PROJECT AIMED AT DEVELOPING BIOMEDICINE FROM PLURIPOTENT STEM CELLS ➞ Press communication : GoLiver_CP_Subvention_France_Relance_20210318 EN.pdf ➞ https://www.latribune.fr/entreprises-finance/industrie/chimie-pharmacie/therapie-cellulaire-goliver-therapeutics-sur-les-traces-de-l-arn-messager-880289.html ➞ https://www.lesechos.fr/pme-regions/innovateurs/goliver-parie-sur-les-cellules-souches-pour-reparer-le-foie-1299316 ➞ https://nantes.maville.com/actu/actudet_–medecine-regenerative-un-nouveau-pas-de-geant-pour-la-start-up-nantaise-goliver-_fil-4544852_actu.Htm ➞ https://biotechinfo.fr/article/goliver-therapeutics-obtient-un-avis-scientifique-positif-de-lagence-europeenne-du-medicament-ema-sur-sa-strategie-de-developpement-clinique-et-de-bioproduction-dans-linsuffisance/ 11/2020: GoLiver Therapeutics is […]